Publications related to project ISOLDA – part 3

Since 2020, the ISOLDA consortium has been collaborating to develop improved vaccines against viral infections for older adults. The collaboration has resulted in a number of peer-reviewed articles in academic journals. Over the coming months, we will share these articles in the News section of our website.

Following part 1 and part 2 of this blog series, the consortium is proud to present the next five academic publications related to project ISOLDA:

#TitleAuthorsJournalDOI and URL
11CAR-T Cells for the Treatment of Lung CancerLuisa Chocarro, Hugo Arasanz, Leticia Fernández-Rubio, Ester Blanco, Miriam Echaide, Ana Bocanegra, Lucía Teijeira, Maider Garnica, Idoia Morilla, Maite Martínez-Aguillo, Sergio Piñeiro-Hermida, Pablo Ramos, Juan José Lasarte, Ruth Vera, Grazyna Kochan, David Escors Life10.3390/life12040561 View here
12FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus InfectionsRobert Meineke, Sonja Stelz, Maximilian Busch, Christopher Werlein, Mark Kühnel, Danny Jonigk, Guus F. Rimmelzwaan, Husni ElbaheshViruses10.3390/v14092058 View here
13MERS-CoV ORF4b is a virulence factor involved in the inflammatory pathology induced in the lungs of miceMelissa Bello-Perez, Jesús Hurtado-Tamayo, Ricardo Requena-Platek, Javier Canton, Pedro José Sánchez-Cordón, Raúl Fernandez-Delgado, Luis Enjuanes, Isabel SolaPLOS Pathogens 10.1371/journal.ppat.1010834 View here
14How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity CellsMaider Garnica, Anna Aiello, Mattia Emanuela Ligotti, Giulia Accardi, Hugo Arasanz, Ana Bocanegra, Ester Blanco, Anna Calabrò, Luisa Chocarro, Miriam Echaide, Grazyna Kochan, Leticia Fernandez-Rubio, Pablo Ramos, Fanny Pojero, Nahid Zareian, Sergio Piñeiro-Hermida, Farzin Farzaneh, Giuseppina Candore, Calogero Caruso, David EscorsInternational Journal of Molecular Sciences10.3390/ijms23179797 View here
15Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 InhibitorLuisa Chocarro, Ana Bocanegra, Ester Blanco, Leticia Fernández-Rubio, Hugo Arasanz, Miriam Echaide, Maider Garnica, Pablo Ramos, Sergio Piñeiro-Hermida, Ruth Vera, David Escors, Grazyna KochanCells10.3390/cells11152351 View here

Related Posts